U.S. Markets closed

NeuroMetrix strength attributed to 510(k) Premarket Notification

The move higher in shares of NeuroMetrix is being attributed to the FDA's posting, dated July 1, of the company receiving 510(k) Premarket Notification for its pain reliever device.